多汗症治療 - MiraDry微波技術

多汗症治療,MiraDry微波技術,獲美國食物及藥物衛生局(FDA)認可的非入侵性MiraDry微波技術,能快速地為原發性腋下多汗症患者進行治療,除了減少外科手術切除汗腺的風險外,多汗症治療不再屬暫時性,而是效果持久。患者不用住院,在專科醫生診所進行便可。

多汗症治療 - MiraDry微波技術

相比傳統多汗症治療方法,獲美國食物及藥物衛生局(FDA)認可的非入侵性MiraDry微波技術,能快速地為原發性腋下多汗症患者進行治療,除了減少外科手術切除汗腺的風險外,多汗症治療不再屬暫時性,而是效果持久。

進行MiraDry療程,患者不用住院,在專科醫生診所進行便可。外科醫生在治療前會在患者腋下進行局部麻醉,然後將MiraDry機頭貼向腋下皮膚,透過發放微波能量,以非入侵性方式消除腋下汗腺。

由於該多汗症治療技術所發放的微波是直達汗腺的真皮層,並不受皮膚厚度影響,加上備有水瓷冷卻技術,不會令皮膚受損。由於被切除的汗腺不會再增生,故此MiraDry療程能有效解決腋下多汗症、狐臭問題,無毒素外,且效果持久,過程快捷,而在最近一次臨床研究中,進行MiraDry治療後,患者的汗液分泌減少的平均值達八成。

進行MiraDry治療會否阻礙日常生活?

進行MiraDry治療後,患者可即日投入工作,並可在數天後如常做運動。有關治療的康復期較手術短,如感到患處出現局部酸痛或腫脹,屬於正常現象,可使用冰袋外敷,舒緩不適,而醫生也會處方止痛藥作不時之需。一般情況下,腫脹酸痛在數週後便會消退。

安全

治療是非侵入性,無需開刀,無需全身麻醉,你亦不需要擔心治療後會留下留疤。

持久

經由系統準確控制微波,能量選擇性直達汗腺密集分佈的皮膚組織,並非消滅所有汗腺,通常分兩次療程以達到最佳的治療效果。

高效

根據刊登於Cosmetic and Laser Therapy的研究報告指出,患者的出汗程度不同,大部分患者接受第一次療程結束後,患者會感覺到有明顯和即時效果,出汗量驟減及汗水減少。

下表列出了11名亞洲人分別患有多汗症(Hyperhidrosis)以及腋臭(Osmidrosis)患者在進行miraDry療程前後的變化。無論是在多汗症嚴重度分級表(HDSS)以及氣味等級(Odor Grade),大部分的患者經miraDry技術治療後(83.3%),無論於嚴重度分級及氣味等級中,都有至少兩級的進步,部分患者更有三級的進步。93.8%的療程後患者達到良好至優秀結果。


New Study Shows MiraDry Reduces Underarm Sweating by 96%

A new independent study conducted at the Albert Einstein College of Medicine in New York found the non-invasive miraDryprocedure provides a long-term solution to the problem ofexcessive underarm sweat and a marked improvement in underarm odor.

MiraDry non-invasively delivers targeted electromagnetic energy beneath the underarm skin to where the sweat glands reside destroying the sweat glands through thermolysis (decomposition by heat). Results can be seen almost immediately and are lasting because sweat glands do not grow back after treatment. Two procedures spaced three months apart are recommended for optimal results.

The findings of this study were presented by Dr. Cameron K. Rokhsar, MD FAAD FAACS, lead investigator for the study, and medical director of the New York Cosmetic, Skin & Laser Surgery Center at the 2013 American Society for Laser Medicine and Surgery annual meeting. The study included 13 women and 7 men between the ages of 22 and 56. Participants reported suffering from excessive sweating (hyperhidrosis) for an average of 13.6 years. Prior to receiving the miraDry treatment the patients reported an excessive sweating severity of an average of 8 on a scale of 1 to 10 (with 10 being the most severe).

After one miraDry treatment, patients reported an average reduction of 52% in underarm sweating. After two treatments, patients reported an average reduction of 96.7% in underarm sweating. Among patients who said they had odor problems before treatment, the majority (75%) reported an average of 66% reduction in underarm odor. Side effects included swelling in the underarms after the procedure which lasted from 5 days to 2 months, with an average of 24.8 days. 65% of patients also noticed hair loss in the treated areas.

Dr. Rokhsar speculates that future miraDry uses, considering skin structures across the body, could include supra pubic (above the pubic area) hyperhidrosis treatment or back treatment. Those would be interesting developments but are not currently FDA-cleared. Keep watching this newsletter and go to www.miraDry.com for updates. To find a miraDry physician near you, click here.



本網站上的資訊僅提供教育用途。你應該諮詢醫生有關的治療方法,而不應依賴網站上的資訊。